L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3281
ETF rank
โ‚น2.70 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น1,372
Share price
-0.30%
Change (1 day)
19.92%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of October 2026: 0.49%